Physician profile
Lawrence Halperin
NPI 1801894977
$1,181.81
in general payments reported to CMS, 2019-2025
9 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.90 · 2020: $165 · 2021: $128 · 2022: $210 · 2023: $368 · 2024: $53.85 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $549.08 | 2019-2023 | Vabysmo, Lunsumio |
| Regeneron Healthcare Solutions, INC. | $262.63 | 2020-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $143.51 | 2022 | |
| Viiv Healthcare Company | $92.50 | 2023-2024 | Cabenuva |
| Novartis Pharmaceuticals Corporation | $37.96 | 2019-2020 | |
| Alcon Vision LLC | $37.51 | 2024-2025 | Unity, Constellation |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.29 | 2019 | |
| Glaukos Corporation | $19.09 | 2024 | Idose |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Halperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.